Home/Pipeline/CSPC-DM02

CSPC-DM02

Solid Tumors

Phase 2Active

Key Facts

Indication

Solid Tumors

Phase

Phase 2

Status

Active

Company

CSPC Pharmaceutical Group Limited

About CSPC Pharmaceutical Group Limited

CSPC Pharmaceutical Group is a leading Chinese pharmaceutical company with a diversified portfolio spanning innovative drug development, generic medicines, and pharmaceutical manufacturing. Founded in 1997 and publicly traded on the Hong Kong Stock Exchange, the company has established itself as a major player in China's pharmaceutical industry with strong R&D capabilities and extensive manufacturing infrastructure. CSPC focuses primarily on oncology, CNS disorders, and metabolic diseases, with multiple products in clinical development and a robust commercial portfolio serving both domestic and international markets.

View full company profile

Therapeutic Areas

Oncology Central Nervous System Metabolic Diseases Nephrology Respiratory

Other Solid Tumors Drugs

Drug	Company	Phase	Status
GSK4362676	GSK plc	Phase 1	Active
ABBV-154	AbbVie	Phase 1	Active
TAK-981	Takeda Pharmaceutical	Phase 1/2	Active
TAK-676	Takeda Pharmaceutical	Phase 1	Active
TAK-573	Takeda Pharmaceutical	Phase 1	Active
TAK-164	Takeda Pharmaceutical	Phase 1	Active
SHR-1316	Jiangsu Hengrui Medicine	Phase 1/2	Active
BAY 2927088	Bayer	Phase 1	Active
ASP1929	Astellas Pharma	Phase 2	Active
IBI188	Innovent Biologics	Phase 1	Active
Bispecific Antibody	Akeso	Phase 1/2	Active
ONO-4538 combinations	Ono Pharmaceutical	Phase 2	Active